Olaplex stock jumps after receiving first buy rating from Wall Street

Olaplex Holdings (OLPX) stock surged 12% after receiving its first Wall Street 'Buy' rating from Canaccord Genuity, which set a $2.00 price target. The upgrade signals a potential turning point for the prestige beauty brand, with the analyst citing 'brand reinvigoration' and stabilizing sales and margins after a period of normalization, projecting a return to positive annual growth in FY2025. While adjusted EBITDA margins have settled to industry-standard low-20% from over 60%, the move reflects growing confidence that investments are yielding results.

Analysis

Olaplex Holdings (OLPX) experienced a significant 12% stock price increase following a pivotal upgrade from Canaccord Genuity, which marks the first 'Buy' rating for the company among its approximately nine Wall Street analyst firms. The analyst raised the price target to $2.00 from $1.50, citing a "brand reinvigoration" as the primary catalyst for a potential return to growth. This upgrade is predicated on the view that Olaplex has concluded a 2.5-year normalization period, during which annualized sales contracted from over $700 million to a more stable $400 million run rate. Key financial indicators supporting this thesis include sales growth in the second quarter and stabilizing margins. While adjusted EBITDA margins have compressed significantly from historical highs above 60% to an industry-standard low-20% range, this stabilization is viewed as a positive sign of a more sustainable business model. The market's strong reaction suggests growing investor confidence that the company's strategic investments in marketing and innovation are beginning to materialize, with a potential return to positive annual growth projected for fiscal year 2025.

Key Decisions for Investors

• Investors should weigh this initial 'Buy' rating as a potential, albeit contrarian, early signal of a fundamental turnaround, noting it is the sole bullish call among the covering analyst firms.
• Future investment decisions should be contingent on the company delivering on key metrics cited in the upgrade, specifically continued sales stabilization and a clear path toward the projected positive annual growth in fiscal year 2025.
• It is crucial to re-evaluate the stock's valuation based on the new norm of industry-standard low-20% EBITDA margins, as this reflects a fundamental shift in the company's long-term profitability profile from its previous 60%-plus levels.